This announcement comes on the heels of the Food and Drug Administration (FDA) approving Foundayo for adults with obesity or those who are overweight with related health conditions. The once-daily GLP ...
Biopharma giants Eli Lilly and Regeneron and rapidly growing contract manufacturers Fujifilm and Cellares, are among the ...
Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has ...
June 29 (Reuters) - The U.S. Food and Drug Administration on Monday selected Eli Lilly, Regeneron and five other companies ...
Eli Lilly, Regeneron, and five other companies have been selected to take part in the FDA's PreCheck pilot programme, designed to make it easier and quicker to set up US manufacturing facilities. The ...
May 6 (Reuters) - Eli Lilly said on Wednesday ⁠it ⁠would invest $4.5 billion more ⁠across two of its three manufacturing sites in Indiana, bringing the U.S. drugmaker's total capital expansion ...
Eli Lilly plans to invest more than $3.5 billion in a new injectable medicine and device manufacturing facility in Pennsylvania. The Lehigh Valley site will manufacture next-generation weight-loss ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The state is providing $100 ...
June 29 (Reuters) - The U.S. Food and Drug Administration has selected Eli Lilly, Regeneron and five other companies for a ...
Food and Drug Administration has ‌selected Eli Lilly and Regeneron ‌among seven companies for a pilot ​program to accelerate ...